| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.036 | 0.5 |